PMID: 6407638Jun 18, 1983Paper

Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy

British Medical Journal
J FidlerM De Swiet

Abstract

One hundred pregnant women with hypertension (defined as diastolic blood pressure at or above 95 mm Hg) were allocated at random to treatment with methyldopa or oxprenolol and were compared with nonhypertensive controls matched according to parity and gestation at delivery. The patients were also stratified into those entering the study early (before 32 weeks' gestation) and those entering late (after 32 weeks' gestation). Although there were no differences in diastolic blood pressure between the hypertensive groups before or during treatment, in the early entry group the systolic blood pressure at entry of those allocated to oxprenolol was significantly higher than that of those receiving methyldopa; this difference remained throughout the treatment period. Also in the early entry group further increments of drug treatment were required to control blood pressure of patients receiving oxprenolol than in those receiving methyldopa. The eventual fetal outcome for all patients treated with methyldopa was the same as that for those treated with oxprenolol; birth weight, placental weight, head circumference, and Apgar score were not significantly different and there were no stillbirths in either group.

References

Mar 11, 1978·British Medical Journal·G V ChamberlainC J Bulpitt
Feb 14, 1970·Lancet·B M Wright, C F Dore
Oct 1, 1969·The Journal of Obstetrics and Gynaecology of the British Commonwealth·A M ThomsonF E Hytten
Jun 6, 1981·Lancet·M D Jaffe
Nov 26, 1981·The New England Journal of Medicine·P C Rubin
Jan 1, 1981·Journal of Cardiovascular Pharmacology·B N Prichard, D A Richards

❮ Previous
Next ❯

Citations

Jan 1, 1990·European Journal of Clinical Pharmacology·M J BoutroyA Zipfel
Jan 1, 1984·European Journal of Clinical Pharmacology·M F O'HareD G McDevitt
Jan 1, 1990·European Journal of Clinical Pharmacology·P L MorselliP Vert
May 15, 2012·Archives of Gynecology and Obstetrics·Stefano R GiannubiloAndrea L Tranquilli
Aug 1, 1986·European Journal of Obstetrics, Gynecology, and Reproductive Biology·J RosenfeldE Zmora
Jan 1, 1997·Pharmacology & Therapeutics·S M KhedunB Maharaj
Jul 25, 1996·The New England Journal of Medicine·B M Sibai
Nov 1, 1984·Archives of Disease in Childhood·B ReynoldsP C Rubin
Jan 5, 1985·British Medical Journal·R CollinsR Peto
Apr 6, 1985·British Medical Journal·M Ounsted, C W Redman
Aug 10, 1985·British Medical Journal·M deSwiet
Feb 7, 1987·British Medical Journal·K R Lees, P C Rubin
Sep 22, 1990·BMJ : British Medical Journal·L ButtersP C Rubin
Jan 5, 2014·Journal of Hypertension·Khalid A J Al KhajaAwatif H H Damanhori
Mar 30, 2010·Annales Françaises D'anesthèsie Et De Rèanimation·R SerreauUNKNOWN Société française de anesthésie et de réanimation
Feb 5, 2000·European Journal of Obstetrics, Gynecology, and Reproductive Biology·L A MageeG Koren
Sep 1, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G Remuzzi, P Ruggenenti
Apr 1, 1987·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C W Redman
Jan 1, 1993·American Journal of Obstetrics and Gynecology·S MontanS S Ratnam
Jan 27, 2011·Seminars in Nephrology·Tiina Podymow, Phyllis August
Apr 1, 1987·Australian and New Zealand Journal of Medicine·P Kincaid-Smith
May 15, 1997·The American Journal of Cardiology·G Y LipD G Beevers
Sep 17, 2004·Hypertension in Pregnancy : Official Journal of the International Society for the Study of Hypertension in Pregnancy·E J WatermanP von Dadelszen
Jan 1, 1984·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·P C Rubin
Feb 1, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C W Redman
Oct 18, 2000·The Cochrane Database of Systematic Reviews·L A Magee, L Duley
Feb 9, 2008·Hypertension·Tiina Podymow, Phyllis August
May 24, 2017·Hypertension·Maria HoeltzenbeinChristof Schaefer
Oct 3, 2018·The Cochrane Database of Systematic Reviews·Edgardo AbalosCelina Gialdini
Apr 1, 1987·British Journal of Obstetrics and Gynaecology·P C Rubin
Apr 4, 2019·Expert Opinion on Pharmacotherapy·Juan TamargoEva Delpón
Feb 8, 2014·The Cochrane Database of Systematic Reviews·Edgardo AbalosD Wilhelm Steyn
Mar 1, 1991·British Journal of Obstetrics and Gynaecology·S Blake, D MacDonald
Mar 9, 1985·British Medical Journal·P CritchleyC D Marsden
Aug 15, 2003·The Cochrane Database of Systematic Reviews·L A Magee, L Duley
Jun 3, 2015·Journal of Cardiovascular Pharmacology and Therapeutics·Meghan N McCombTien M H Ng
Jun 1, 2012·Obstetric Medicine·D KernaghanG A McKay
Apr 23, 2019·SAGE Open Medicine·Stephanie Braunthal, Andrei Brateanu
May 1, 1984·The Australian & New Zealand Journal of Obstetrics & Gynaecology·E D Gallery

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.